Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 Par Value
-
Shares outstanding
-
117M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
88.5M
-
Shares change
-
+13.4M
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$159M
-
Put/Call ratio
-
0.06
-
Number of buys
-
76
-
Number of sells
-
-55
-
Price
-
$11.84
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) as of Q2 2023
152 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value as of Q2 2023.
Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88.5M shares
of 117M outstanding shares and own 75.98% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.42M shares), TCG Crossover Management, LLC (5.63M shares), COMMODORE CAPITAL LP (5.57M shares), BlackRock Inc. (5.48M shares), Point72 Asset Management, L.P. (4.69M shares), VR Adviser, LLC (4.68M shares), VANGUARD GROUP INC (4.44M shares), Fairmount Funds Management LLC (3.56M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.44M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.37M shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.